Work

A phase Ib/IIa study of NEO-102: A therapeutic antibody to treat pancreatic and colorectal cancers.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.3_suppl.243

Authors: Sandip Pravin Patel, Michael Morse, Muhammad Shaalan Beg, Nilofer Saba Azad, Melony A. Beatson, Sharon Mavroukakis, Philip M. Arlen

Institutions: Duke Medical Center, The University of Texas Southwestern Medical Center, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590430429

Cites:

Cited by: 2

Related to: 10